Are teicoplanin-non-susceptible Staphylococcus epidermidis strains increasing?
Por um escritor misterioso
Descrição
Researchers elucidated the incidence patterns of teicoplanin-non-susceptible Staphylococcus epidermidis (Teico-NS S. epidermidis) over six years.
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
Antibiotics, Free Full-Text
Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trial - eClinicalMedicine
β-Lactam and glycopeptide antibiotics: first and last line of defense?: Trends in Biotechnology
Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia
IJMS, Free Full-Text
Are teicoplanin-non-susceptible Staphylococcus epidermidis strains increasing?
Limitations of presently available glycopeptides in the treatment of Gram‐positive infection - Ziglam - 2001 - Clinical Microbiology and Infection - Wiley Online Library
Frontiers Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
Characterization of Teicoplanin Nonsusceptible Staphylococcus epidermidis Clinical Isolates Belonging Predominantly to ST267
Full article: Increasing prevalence of hypervirulent ST5 methicillin susceptible Staphylococcus aureus subtype poses a serious clinical threat
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
